Correlation Between GlaxoSmithKline PLC and Allianzgi Nfj

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Allianzgi Nfj at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Allianzgi Nfj into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Allianzgi Nfj Dividend, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Allianzgi Nfj and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Allianzgi Nfj. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Allianzgi Nfj.

Diversification Opportunities for GlaxoSmithKline PLC and Allianzgi Nfj

-0.58
  Correlation Coefficient

Excellent diversification

The 3 months correlation between GlaxoSmithKline and Allianzgi is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Allianzgi Nfj Dividend in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allianzgi Nfj Dividend and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Allianzgi Nfj. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allianzgi Nfj Dividend has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Allianzgi Nfj go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Allianzgi Nfj

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Allianzgi Nfj. In addition to that, GlaxoSmithKline PLC is 2.37 times more volatile than Allianzgi Nfj Dividend. It trades about -0.24 of its total potential returns per unit of risk. Allianzgi Nfj Dividend is currently generating about 0.09 per unit of volatility. If you would invest  1,126  in Allianzgi Nfj Dividend on August 28, 2024 and sell it today you would earn a total of  29.00  from holding Allianzgi Nfj Dividend or generate 2.58% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Allianzgi Nfj Dividend

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Allianzgi Nfj Dividend 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Allianzgi Nfj Dividend are ranked lower than 8 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong technical and fundamental indicators, Allianzgi Nfj is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

GlaxoSmithKline PLC and Allianzgi Nfj Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Allianzgi Nfj

The main advantage of trading using opposite GlaxoSmithKline PLC and Allianzgi Nfj positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Allianzgi Nfj can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allianzgi Nfj will offset losses from the drop in Allianzgi Nfj's long position.
The idea behind GlaxoSmithKline PLC ADR and Allianzgi Nfj Dividend pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance